PROLUNG INC
SALT LAKE CITY, UT · CIK 0001541884 · Medtech · Defunct
Extended-release drug delivery system that converts multiple daily doses into single-dose formulations
vgsktechnologies.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.8M
- 5 Form D · Dec 2020
- 70 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $1,256,931 | |
| Private capital raised | Form D · SEC | $516,055 | |
| Private capital raised | Form D · SEC | $824,000 | |
| Private capital raised | Form D · SEC | $182,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1978 | NGOGGLE, INC. | — | — |
| 1979 | Bioliberty Ltd | — | $2.9M |
| 1980 | TRICORDER ARRAY TECHNOLOGIES, LLC | — | — |
| 1981 | PROLUNG INC | — | $2.8M |
| 1982 | ATILA BIOSYSTEMS, INC. | — | — |
| 1983 | Spine Align LLC | — | — |
| 1984 | VERSAGO VASCULAR ACCESS, INC. | — | $440K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Wayne AdamsDirector
- Mark AndersonExecutive Officer
- Jared BauerExecutive Officer
- Neil BerkleyDirector
- Clark CampbellDirector
- Steven ErorDirector · Executive Officer
- Michael GarffDirector · Executive Officer
- Jim HoganDirector
- Richard McKeownDirector
- Garff MichaelDirector · Executive Officer
- Todd MorganDirector
- David NielsenDirector
- J NixonDirector
- J. NixonDirector
- Jeffrey O'DriscollDirector
- Don PattersonDirector
- Robert RaybouldDirector
- John RuckdeschelDirector
- Robin SmithDirector
- Aaron StoutExecutive Officer
- Treu TimDirector
- Tim TreuDirector
- Dennis TulaneDirector
Patents
- Methods, Systems, And Devices For Determining And Maintaining A Consistent Ground And Ground Saturation Resistancegranted
- Conductivity Compensation Factor For Assessing Bioelectric Measurementsapplication
- Devices, Systems And Methods For Controlling A Spring Force Exerted On A Sensor For Obtaining Bio-conductance Readings Using A Linear Actuatorapplication
- Conductivity Compensation Factor For Assessing Bioelectric Measurementsgranted
- Methods, Systems, And Devices For Incorporating Vibration Therapy And Vibration Feedback Into A Bioelectric Test Probeapplication
- Methods, Systems, And Devices For Controlling Temperature In A Bioelectric Measurement Systemapplication
- Maintaining Surface Moisture To Aid In Acquiring A Consistent Ground During Bio-conductance Testingapplication
- Probe Having Multiple Tips And An Indicator For Obtaining Bioelectrical Signalsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.